Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Alberta A Davis"'
Publikováno v:
Survey of Ophthalmology. 52:S62-S69
To develop a safe and effective transcleral delivery of anecortave acetate, a novel angiostatic cortisene, in therapeutic concentrations to the choroid and retina in the region of the macula in patients with age related macular degeneration.In pre-cl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::38281092b082961975f00bd6362b2b60
https://doi.org/10.1016/j.survophthal.2006.10.015
https://doi.org/10.1016/j.survophthal.2006.10.015
Autor:
M.V. W. Bergamini, Alberta A Davis, Scott Krueger, Lewis H. Silver, Alan L. Weiner, E. Kenneth Sullivan, Stella M. Robertson, Peter A. Netland
Publikováno v:
Advances in Therapy. 20:149-163
Two prospective, controlled, multicenter, double-masked studies--one lasting 6 months (n=594) and the other, 12 months (n=787)--examined the intraocular pressure (IOP)-lowering efficacy of travoprost in 1381 black and nonblack patients with open-angl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7bd8dbe9884de176088c0e9a924282bd
https://doi.org/10.1007/bf02850202
https://doi.org/10.1007/bf02850202
Autor:
Marla Ratliff, Alan L. Weiner, Alberta A Davis, E. Kenneth Sullivan, Jess T. Whitson, Ronald L. Fellman, F. Darell Turner, Lewis H. Silver
Publikováno v:
Ophthalmology. 109:998-1008
Objective To compare the safety and intraocular pressure (IOP)-lowering efficacy of once-daily travoprost (0.0015% and 0.004%) to twice-daily timolol 0.5%. Design Prospective, 6-month, randomized, controlled, multicenter, double-masked, phase III stu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1da46541cc90aef53386bd2a6c3d411a
https://doi.org/10.1016/s0161-6420(02)01010-2
https://doi.org/10.1016/s0161-6420(02)01010-2
Autor:
Jaime E. Dickerson, Russell M. Andrew, Lewis H. Silver, Theresa A. Landry, E. Kenneth Sullivan, Alberta A Davis, Michael V. W. Bergamini, Peter A. Netland, Alan L. Weiner, Sushanta Mallick, Stella M. Robertson
Publikováno v:
American Journal of Ophthalmology. 132:472-484
● PURPOSE: This study evaluated the safety and intraocular pressure–lowering efficacy of two concentrations of travoprost (0.0015% and 0.004%) compared with latanoprost 0.005% and timolol 0.5% in patients with open-angle glaucoma or ocular hypert
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a0826d79c3b67782df4228fe0c127e70
https://doi.org/10.1016/s0002-9394(01)01177-1
https://doi.org/10.1016/s0002-9394(01)01177-1
Autor:
Michelle Chang, Peter A. Campochiaro, Steven Goldflam, Donald J. Zack, John W. Crabb, Breandán N. Kennedy, Alberta A. Davis
Publikováno v:
Journal of Biological Chemistry. 273:5591-5598
Cellular retinaldehyde-binding protein (CRALBP) is abundantly expressed in the retinal pigment epithelium (RPE) and Muller cells of the retina, where it is thought to function in retinoid metabolism and visual pigment regeneration. Mutations in human
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f9b59807453994b900f186800d3f423e
https://doi.org/10.1074/jbc.273.10.5591
https://doi.org/10.1074/jbc.273.10.5591
Autor:
Richard C. Hunt, Alberta A. Davis
Publikováno v:
Journal of Cellular Physiology. 152:102-110
Retinal pigment epithelial cells, which form one aspect of the blood-retinal barrier, take up iron in association with transferrin by a typical receptor-mediated mechanism (Hunt et al., 1989. J. Cell Sci. 92:655-666). This iron is dissociated from tr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f7198a175f0309164ba0c2ec27faa679
https://doi.org/10.1002/jcp.1041520114
https://doi.org/10.1002/jcp.1041520114
Autor:
Richard C. Hunt, Alberta A. Davis
Publikováno v:
Journal of Cellular Physiology. 145:187-199
Actively proliferating human retinal pigment epithelial (RPE) cells grown in tissue culture possess keratin-containing intermediate filaments that react with a combination of AE1 and AE3 anti-keratin monoclonal antibodies. Antibody reactivity is lost
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0e25f5c088f4b0a8610bffea4eff61cb
https://doi.org/10.1002/jcp.1041450202
https://doi.org/10.1002/jcp.1041450202
Publikováno v:
Ocular Angiogenesis ISBN: 9781588295149
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9eea72f0c0c92e0df4e1a9e0379a5411
https://doi.org/10.1007/978-1-59745-047-8_19
https://doi.org/10.1007/978-1-59745-047-8_19
Autor:
Angela C. Kothe, Alan L. Weiner, Verney L. Sallee, N.A. Sharif, Evan P. Kyba, Stella M. Robertson, John E Bishop, Lewis H. Silver, Michael V.W. Bergamini, Paul W Zinke, Mark R. Hellberg, Peter G. Klimko, Louis Desantis, Joseph M. deFaller, Alberta A Davis, Thomas R. Dean, George Barnes, Theresa A. Landry, Marsha A. McLaughlin, Robert D. Selliah, Russell M. Andrew, E. Kenneth Sullivan
Publikováno v:
Survey of ophthalmology. 47
The structure-activity studies that led to the identification of travoprost, a highly selective and potent FP prostaglandin analog, and AL-6598, a DP prostaglandin analog, are detailed. In both series, the 1-alcohol analogs are very effective and are
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bc76a86c3a5467435cc63605dec04dc0
https://pubmed.ncbi.nlm.nih.gov/12204698
https://pubmed.ncbi.nlm.nih.gov/12204698
Autor:
Ronald L, Fellman, E Kenneth, Sullivan, Marla, Ratliff, Lewis H, Silver, Jess T, Whitson, F Darell, Turner, Alan L, Weiner, Alberta A, Davis
Publikováno v:
Ophthalmology. 109(5)
To compare the safety and intraocular pressure (IOP)-lowering efficacy of once-daily travoprost (0.0015% and 0.004%) to twice-daily timolol 0.5%.Prospective, 6-month, randomized, controlled, multicenter, double-masked, phase III study.Six hundred fiv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::68da04284b95f9f917f38d7a843fb9fb
https://pubmed.ncbi.nlm.nih.gov/11986110
https://pubmed.ncbi.nlm.nih.gov/11986110